{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:40:18Z","timestamp":1791909618790,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH","award":["HL56921"],"award-info":[{"award-number":["HL56921"]}]},{"name":"NIH","award":["HL33610"],"award-info":[{"award-number":["HL33610"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Regulatory Peptides"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.regpep.2012.05.093","type":"journal-article","created":{"date-parts":[[2012,5,14]],"date-time":"2012-05-14T03:34:11Z","timestamp":1336966451000},"page":"107-115","source":"Crossref","is-referenced-by-count":70,"title":["Oral administration of an angiotensin-converting enzyme 2 activator ameliorates diabetes-induced cardiac dysfunction"],"prefix":"10.1016","volume":"177","author":[{"given":"Tatiane M.","family":"Mur\u00e7a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia L.","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina A.B.","family":"Capuru\u00e7o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9rgio H.S.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos B.","family":"Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robson A.S.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinayak","family":"Shenoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Katovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohan K.","family":"Raizada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anderson J.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.regpep.2012.05.093_bb0005","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","article-title":"New type of cardiomyopathy associated with diabetic glomerulosclerosis","volume":"30","author":"Rubler","year":"1972","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.regpep.2012.05.093_bb0010","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1161\/CIRCULATIONAHA.106.679597","article-title":"Diabetic cardiomyopathy revisited","volume":"115","author":"Boudina","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.regpep.2012.05.093_bb0015","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jacc.2008.10.008","volume":"53","author":"Skyler","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.regpep.2012.05.093_bb0020","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/S0140-6736(08)60768-0","article-title":"Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies","volume":"371","author":"Mazzone","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.regpep.2012.05.093_bb0025","doi-asserted-by":"crossref","first-page":"421","DOI":"10.7326\/0003-4819-141-6-200409210-00007","article-title":"Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus","volume":"141","author":"Selvin","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.regpep.2012.05.093_bb0030","doi-asserted-by":"crossref","first-page":"10A","DOI":"10.1016\/j.amjcard.2009.10.006","article-title":"Progression of cardiovascular damage: the role of renin\u2013angiotensin system blockade","volume":"105","author":"Probstfield","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.regpep.2012.05.093_bb0035","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrneph.2010.58","article-title":"The RAAS in the pathogenesis and treatment of diabetic nephropathy","volume":"6","author":"Ruggenenti","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.regpep.2012.05.093_bb0040","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1161\/HYPERTENSIONAHA.109.138420","article-title":"Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension","volume":"55","author":"Wysocki","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.regpep.2012.05.093_bb0045","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/CIRCULATIONAHA.110.955369","article-title":"Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction","volume":"122","author":"Zhong","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.regpep.2012.05.093_bb0050","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1113\/expphysiol.2010.055277","article-title":"Angiotensin-converting enzyme 2 activation protects against hypertension-induced cardiac fibrosis involving extracellular signal-regulated kinases","volume":"96","author":"Ferreira","year":"2011","journal-title":"Exp Physiol"},{"key":"10.1016\/j.regpep.2012.05.093_bb0055","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/HYPERTENSIONAHA.109.141622","article-title":"Angiotensin-(1\u20137)-angiotensin-converting enzyme 2 attenuates reactive oxygen species formation to angiotensin II within the cell nucleus","volume":"55","author":"Gwathmey","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.regpep.2012.05.093_bb0060","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2119\/molmed.2009.00160","article-title":"ACE2 activation promotes antithrombotic activity","volume":"16","author":"Fraga-Silva","year":"2010","journal-title":"Mol Med"},{"key":"10.1016\/j.regpep.2012.05.093_bb0065","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1161\/CIRCRESAHA.110.219279","article-title":"Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse","volume":"107","author":"Thomas","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.regpep.2012.05.093_bb0070","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1\u20139","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.regpep.2012.05.093_bb0075","doi-asserted-by":"crossref","first-page":"33238","DOI":"10.1074\/jbc.M002615200","article-title":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase","volume":"275","author":"Tipnis","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.regpep.2012.05.093_bb0080","doi-asserted-by":"crossref","first-page":"14838","DOI":"10.1074\/jbc.M200581200","article-title":"Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase","volume":"277","author":"Vickers","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.regpep.2012.05.093_bb0085","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators","volume":"325","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.regpep.2012.05.093_bb0090","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.regpep.2012.05.093_bb0095","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMoa010713","article-title":"A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure","volume":"345","author":"Cohn","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.regpep.2012.05.093_bb0100","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(03)14282-1","article-title":"Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-overall programme","volume":"362","author":"Pfeffer","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.regpep.2012.05.093_bb0105","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.amjcard.2009.07.018","article-title":"Left ventricular mass and volume with telmisartan, ramipril, or combination in patients with previous atherosclerotic events or with diabetes mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET])","volume":"104","author":"Cowan","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.regpep.2012.05.093_bb0110","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/1753944708094309","article-title":"ACE-inhibitor, AT1-receptor-antagonist, or both? A clinical pharmacologist's perspective after publication of the results of ONTARGET","volume":"2","author":"Schindler","year":"2008","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"10.1016\/j.regpep.2012.05.093_bb0115","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.amjcard.2009.11.044","article-title":"Current status of dual renin angiotensin aldosterone system blockade for the treatment of cardiovascular diseases","volume":"105","author":"Chrysant","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.regpep.2012.05.093_bb0120","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nature00786","article-title":"Angiotensin-converting enzyme 2 is an essential regulator of heart function","volume":"417","author":"Crackower","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.regpep.2012.05.093_bb0125","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.2337\/db09-0782","article-title":"Angiotensin I-converting enzyme type 2 (ACE2) gene therapy improves glycemic control in diabetic mice","volume":"59","author":"Bindom","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.regpep.2012.05.093_bb0130","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2337\/db09-1218","article-title":"Human recombinant ACE2 reduces the progression of diabetic nephropathy","volume":"59","author":"Oudit","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.regpep.2012.05.093_bb0135","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2119\/molmed.2010.00111","article-title":"Angiotensin-converting enzyme (ACE) 2 overexpression ameliorates glomerular injury in a rat model of diabetic nephropathy: a comparison with ACE inhibition","volume":"17","author":"Liu","year":"2011","journal-title":"Mol Med"},{"key":"10.1016\/j.regpep.2012.05.093_bb0140","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1161\/HYPERTENSIONAHA.107.108944","article-title":"Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents","volume":"51","author":"Hernandez Prada","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.regpep.2012.05.093_bb0150","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1164\/rccm.200811-1678OC","article-title":"Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension","volume":"179","author":"Ferreira","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.regpep.2012.05.093_bb0155","unstructured":"Mur\u00e7a TM, Almeida TC, Raizada MK, Ferreira AJ. Chronic Activation of Endogenous Angiotensin-Converting Enzyme 2 Protects Diabetic Rats from Cardiovascular Autonomic Dysfunction. Exp Physiol [2012 Jan 27 Electronic publication ahead of print]."},{"key":"10.1016\/j.regpep.2012.05.093_bb0160","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212delta delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.regpep.2012.05.093_bb0165","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1161\/hc1202.105290","article-title":"New concepts in diastolic dysfunction and diastolic heart failure: part II: causal mechanisms and treatment","volume":"105","author":"Zile","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.regpep.2012.05.093_bb0170","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0014-4800(03)80005-9","article-title":"Different influences of hyperglycemic duration on phosphorylated extracellular signal-regulated kinase 1\/2 in rat heart","volume":"74","author":"Naito","year":"2003","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.regpep.2012.05.093_bb0175","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s00109-004-0579-3","article-title":"Extracellular signal regulated kinase and SMAD signaling both mediate the angiotensin II driven progression towards overt heart failure in homozygous TGR(mRen2)27","volume":"82","author":"de Boer","year":"2004","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.regpep.2012.05.093_bb0180","doi-asserted-by":"crossref","first-page":"H424","DOI":"10.1152\/ajpheart.00110.2003","article-title":"Sarcoplasmic reticulum calcium defect in Ras-induced hypertrophic cardiomyopathy heart","volume":"286","author":"Zheng","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.regpep.2012.05.093_bb0185","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.2337\/db08-0805","article-title":"Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis","volume":"57","author":"Singh","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.regpep.2012.05.093_bb0190","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0925-4439(02)00141-2","article-title":"In vivo treatment with stobadine prevents lipid peroxidation, protein glycation and calcium overload but does not ameliorate Ca2+-ATPase activity in heart and liver of streptozotocin-diabetic rats: comparison with vitamin E","volume":"1588","author":"Pekiner","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.regpep.2012.05.093_bb0195","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/CIRCULATIONAHA.107.728550","article-title":"Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension","volume":"117","author":"van Heerebeek","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.regpep.2012.05.093_bb0200","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.tibs.2003.11.005","article-title":"The AMP-activated protein kinase cascade\u2014a unifying system for energy control","volume":"29","author":"Carling","year":"2004","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.regpep.2012.05.093_bb0205","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.cmet.2009.03.012","article-title":"AMPK: an emerging drug target for diabetes and the metabolic syndrome","volume":"9","author":"Zhang","year":"2009","journal-title":"Cell Metab"},{"key":"10.1016\/j.regpep.2012.05.093_bb0210","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1074\/jbc.271.2.611","article-title":"Mammalian AMP-activated protein kinase subfamily","volume":"271","author":"Stapleton","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.regpep.2012.05.093_bb0215","doi-asserted-by":"crossref","first-page":"12443","DOI":"10.1074\/jbc.273.20.12443","article-title":"Identification of a novel AMP-activated protein kinase beta subunit isoform that is highly expressed in skeletal muscle","volume":"273","author":"Thornton","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.regpep.2012.05.093_bb0220","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cmet.2009.11.008","article-title":"Acute or chronic upregulation of mitochondrial fatty acid oxidation has no net effect on whole-body energy expenditure or adiposity","volume":"11","author":"Hoehn","year":"2010","journal-title":"Cell Metab"},{"key":"10.1016\/j.regpep.2012.05.093_bb0225","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1007\/s00125-005-1962-5","article-title":"Role of AMP-activated protein kinase in the coordinated expression of genes controlling glucose and lipid metabolism in mouse white skeletal muscle","volume":"48","author":"Long","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.regpep.2012.05.093_bb0230","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.1210\/en.2003-0849","article-title":"Minireview: malonyl CoA, AMP-activated protein kinase, and adiposity","volume":"144","author":"Ruderman","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.regpep.2012.05.093_bb0235","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.2337\/diabetes.52.7.1635","article-title":"Glucose autoregulates its uptake in skeletal muscle: involvement of AMP-activated protein kinase","volume":"52","author":"Itani","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.regpep.2012.05.093_bb0240","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1042\/bj20021812","article-title":"Role for AMP-activated protein kinase in glucose-stimulated insulin secretion and preproinsulin gene expression","volume":"371","author":"da Silva Xavier","year":"2003","journal-title":"Biochem J"},{"key":"10.1016\/j.regpep.2012.05.093_bb0245","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1007\/s00018-008-8244-6","article-title":"AMP-activated protein kinase in skeletal muscle: from structure and localization to its role as a master regulator of cellular metabolism","volume":"65","author":"Witczak","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.regpep.2012.05.093_bb0250","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1748-1716.2010.02102.x","article-title":"Impaired cardiac functional reserve in type 2 diabetic db\/db mice is associated with metabolic, but not structural, remodelling","volume":"200","author":"Daniels","year":"2010","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1016\/j.regpep.2012.05.093_bb0255","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/aps.2010.31","article-title":"Improvement of mechanical heart function by trimetazidine in db\/db mice","volume":"31","author":"Li","year":"2010","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.regpep.2012.05.093_bb0260","doi-asserted-by":"crossref","first-page":"H2123","DOI":"10.1152\/ajpheart.00707.2010","article-title":"Enhancing AMPK activation during ischemia protects the diabetic heart against reperfusion injury","volume":"300","author":"Paiva","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"}],"container-title":["Regulatory Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167011512001607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167011512001607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T10:53:59Z","timestamp":1713956039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167011512001607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":51,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0167011512001607"],"URL":"https:\/\/doi.org\/10.1016\/j.regpep.2012.05.093","relation":{},"ISSN":["0167-0115"],"issn-type":[{"value":"0167-0115","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}